Interleukin-22 Promotes Osteosarcoma Cell Proliferation and Invasion via STAT3 Activation.
CONCLUSIONS These results suggest that IL-22 promotes OS cells proliferation and invasion and its effect is mediated by activation of the STAT3 pathway. These findings demonstrate that IL-22 may serve as a promising molecular biomarker for diagnosis and therapy for OS patients.
PMID: 30381753 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Biomedical Science | Bone Cancers | Cancer | Cancer & Oncology | Osteosarcoma | Research | Science | Study